相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma
Yong Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Development of New Cathepsin B Inhibitors: Combining Bioisosteric Replacements and Structure-Based Design To Explore the Structure-Activity Relationships of Nitroxoline Derivatives
Izidor Sosic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The Urinary Antibiotic 5-Nitro-8-Hydroxyquinoline (Nitroxoline) Reduces the Formation and Induces the Dispersal of Pseudomonas aeruginosa Biofilms by Chelation of Iron and Zinc
A. Sobke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Glioblastoma survival in the United States before and during the temozolomide era
Derek R. Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
Whitney B. Pope et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
In vivo models of primary brain tumors: pitfalls and perspectives
Peter C. Huszthy et al.
NEURO-ONCOLOGY (2012)
Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline)
Hongchao Jiang et al.
CANCER LETTERS (2011)
Novel Mechanism of Cathepsin B Inhibition by Antibiotic Nitroxoline and Related Compounds
Bojana Mirkovic et al.
CHEMMEDCHEM (2011)
Rapid and Robust Transgenic High-Grade Glioma Mouse Models for Therapy Intervention Studies
Nienke A. de Vries et al.
CLINICAL CANCER RESEARCH (2010)
Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer
Joong Sup Shim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Pten Deletion in Adult Neural Stem/Progenitor Cells Enhances Constitutive Neurogenesis
Caroline Gregorian et al.
JOURNAL OF NEUROSCIENCE (2009)
Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
Whitney B. Pope et al.
RADIOLOGY (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Is PTEN loss associated with clinical outcome measures in human prostate cancer?
P. McCall et al.
BRITISH JOURNAL OF CANCER (2008)
Pten haploinsufficiency accelerates formation of high-grade astrocytomas
Chang-Hyuk Kwon et al.
CANCER RESEARCH (2008)
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy
David A. Reardon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance
Anamaria Brozovic et al.
CANCER LETTERS (2007)
Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma
Patrick McConville et al.
CLINICAL CANCER RESEARCH (2007)
Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection
J Lazovic et al.
STROKE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cysteine proteases as disease markers
I Berdowska
CLINICA CHIMICA ACTA (2004)
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker
DE Hall et al.
CLINICAL CANCER RESEARCH (2004)
Degradation of extracellular matrix protein tenascin-C by cathepsin B: An interaction involved in the progression of gliomas
JX Mai et al.
BIOLOGICAL CHEMISTRY (2002)
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors
TL Chenevert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
